Literature DB >> 19629622

Enhanced renal accumulation of cisplatin via renal organic cation transporter deteriorates acute kidney injury in hypomagnesemic rats.

Koji Yokoo1, Risa Murakami, Takanobu Matsuzaki, Kanako Yoshitome, Akinobu Hamada, Hideyuki Saito.   

Abstract

BACKGROUND: This study aimed to explore the effects of hypomagnesemia on cisplatin (CDDP)-induced acute kidney injury (AKI) in rats and the relation of hypomagnesemia to the regulation of organic cation transporters and renal accumulation of CDDP.
METHODS: Sprague-Dawley rats were given an Mg-deficient diet starting 7 days before treatment with CDDP. CDDP was administered intravenously to rats in the normal Mg-diet group and Mg-deficient-diet group at 3 mg/kg via the left jugular vein. At the specified periods after injection of CDDP, the amount of platinum in blood and organ samples was determined using inductively coupled plasma-mass spectrometry. Protein expression levels of renal organic cation transporters were determined. Uptake of tetraethylammonium (TEA) bromide in renal slices of rats was measured.
RESULTS: Rats fed a Mg-deficient diet showed a significant body weight decrease and a marked decrease in serum Mg levels compared with control rats fed an adequate Mg diet. Serum blood urea nitrogen and creatinine levels were unaltered after CDDP treatment in control rats, whereas these levels were markedly elevated in hypomagnesemic rats. Immunoblotting revealed up-regulation of the organic cation transporter rOCT2 in hypomagnesemic rats before CDDP administration, but not of rOCT1 or rat multidrug and toxin-extrusion 1. TEA uptake by renal slices from hypomagnesemic rats was significantly higher compared with that of control rats. Renal accumulation of CDDP was markedly increased in hypomagnesemic rats.
CONCLUSION: These results suggest that hypomagnesemia could cause dehydration and up-regulation of rOCT2, enhancing renal accumulation of CDDP and the deterioration of AKI.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19629622     DOI: 10.1007/s10157-009-0215-1

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  28 in total

1.  Inflammatory response following acute magnesium deficiency in the rat.

Authors:  C Malpuech-Brugère; W Nowacki; M Daveau; E Gueux; C Linard; E Rock; J Lebreton; A Mazur; Y Rayssiguier
Journal:  Biochim Biophys Acta       Date:  2000-06-15

Review 2.  Physiological and pharmacokinetic roles of H+/organic cation antiporters (MATE/SLC47A).

Authors:  Tomohiro Terada; Ken-ichi Inui
Journal:  Biochem Pharmacol       Date:  2007-12-27       Impact factor: 5.858

3.  Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin.

Authors:  W B Weglicki; T M Phillips; A M Freedman; M M Cassidy; B F Dickens
Journal:  Mol Cell Biochem       Date:  1992-03-25       Impact factor: 3.396

Review 4.  Cisplatin and hypomagnesemia.

Authors:  H Lajer; G Daugaard
Journal:  Cancer Treat Rev       Date:  1999-02       Impact factor: 12.111

5.  Downregulation of organic anion transporters in rat kidney under ischemia/reperfusion-induced acute [corrected] renal failure.

Authors:  T Matsuzaki; H Watanabe; K Yoshitome; T Morisaki; A Hamada; H Nonoguchi; Y Kohda; K Tomita; K Inui; H Saito
Journal:  Kidney Int       Date:  2007-01-24       Impact factor: 10.612

Review 6.  Magnesium deficiency in critical illness.

Authors:  Garrison M Tong; Robert K Rude
Journal:  J Intensive Care Med       Date:  2005 Jan-Feb       Impact factor: 3.510

7.  Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat.

Authors:  Atsushi Yonezawa; Satohiro Masuda; Kumiko Nishihara; Ikuko Yano; Toshiya Katsura; Ken-ichi Inui
Journal:  Biochem Pharmacol       Date:  2005-10-20       Impact factor: 5.858

8.  Implications of oxidative stress in high sucrose low magnesium diet fed rats.

Authors:  Dharam P Chaudhary; Ravneet K Boparai; Devi D Bansal
Journal:  Eur J Nutr       Date:  2007-09-06       Impact factor: 5.614

9.  Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy.

Authors:  Lin Ji; Satohiro Masuda; Hideyuki Saito; Ken-ichi Inui
Journal:  Kidney Int       Date:  2002-08       Impact factor: 10.612

10.  Altered pharmacokinetics of cationic drugs caused by down-regulation of renal rat organic cation transporter 2 (Slc22a2) and rat multidrug and toxin extrusion 1 (Slc47a1) in ischemia/reperfusion-induced acute kidney injury.

Authors:  Takanobu Matsuzaki; Takafumi Morisaki; Wakako Sugimoto; Koji Yokoo; Daisuke Sato; Hiroshi Nonoguchi; Kimio Tomita; Tomohiro Terada; Ken-ichi Inui; Akinobu Hamada; Hideyuki Saito
Journal:  Drug Metab Dispos       Date:  2008-01-07       Impact factor: 3.922

View more
  19 in total

1.  Prevention of Cisplatin-Induced Acute Kidney Injury: A Systematic Review and Meta-Analysis.

Authors:  Aghilès Hamroun; Rémi Lenain; Jean Joel Bigna; Elodie Speyer; Linh Bui; Paul Chamley; Nicolas Pottier; Christelle Cauffiez; Edmone Dewaeles; Xavier Dhalluin; Arnaud Scherpereel; Marc Hazzan; Mehdi Maanaoui; François Glowacki
Journal:  Drugs       Date:  2019-09       Impact factor: 9.546

2.  Alleviation of cisplatin-induced acute kidney injury using phytochemical polyphenols is accompanied by reduced accumulation of indoxyl sulfate in rats.

Authors:  Masahiro Kusumoto; Hiroki Kamobayashi; Daisuke Sato; Megumi Komori; Misato Yoshimura; Akinobu Hamada; Yukimasa Kohda; Kimio Tomita; Hideyuki Saito
Journal:  Clin Exp Nephrol       Date:  2011-08-23       Impact factor: 2.801

Review 3.  A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity.

Authors:  Daniel J Crona; Aimee Faso; Tomohiro F Nishijima; Kathleen A McGraw; Matthew D Galsky; Matthew I Milowsky
Journal:  Oncologist       Date:  2017-04-24

4.  Premedication with intravenous magnesium has a protective effect against cisplatin-induced nephrotoxicity.

Authors:  Yoshitaka Saito; Masaki Kobayashi; Takehiro Yamada; Kumiko Kasashi; Rio Honma; Satoshi Takeuchi; Yasushi Shimizu; Ichiro Kinoshita; Hirotoshi Dosaka-Akita; Ken Iseki
Journal:  Support Care Cancer       Date:  2016-10-03       Impact factor: 3.603

5.  Magnesium protects against cisplatin-induced acute kidney injury by regulating platinum accumulation.

Authors:  Malvika H Solanki; Prodyot K Chatterjee; Madhu Gupta; Xiangying Xue; Andrei Plagov; Margot H Metz; Rachel Mintz; Pravin C Singhal; Christine N Metz
Journal:  Am J Physiol Renal Physiol       Date:  2014-06-18

6.  Doxycycline attenuates cisplatin-induced acute kidney injury through pleiotropic effects.

Authors:  Terumasa Nakagawa; Yutaka Kakizoe; Yasunobu Iwata; Yoshikazu Miyasato; Teruhiko Mizumoto; Masataka Adachi; Yuichiro Izumi; Takashige Kuwabara; Naoki Suenaga; Yuki Narita; Hirofumi Jono; Hideyuki Saito; Kenichiro Kitamura; Masashi Mukoyama
Journal:  Am J Physiol Renal Physiol       Date:  2018-07-25

7.  Effects of genetic variants in SLC22A2 organic cation transporter 2 and SLC47A1 multidrug and toxin extrusion 1 transporter on cisplatin-induced adverse events.

Authors:  Kazufumi Iwata; Keiji Aizawa; Saori Kamitsu; Sachiko Jingami; Eiko Fukunaga; Minoru Yoshida; Misato Yoshimura; Akinobu Hamada; Hideyuki Saito
Journal:  Clin Exp Nephrol       Date:  2012-05-09       Impact factor: 2.801

8.  The Role of Magnesium Supplementation in Cisplatin-induced Nephrotoxicity in a Rat Model: No Nephroprotectant Effect.

Authors:  Farzaneh Ashrafi; Sara Haghshenas; Mehdi Nematbakhsh; Hamid Nasri; Ardeshir Talebi; Fatemeh Eshraghi-Jazi; Zahra Pezeshki; Tahereh Safari
Journal:  Int J Prev Med       Date:  2012-09

Review 9.  Cisplatin chemotherapy and renal function.

Authors:  Jie Zhang; Zhi-Wei Ye; Kenneth D Tew; Danyelle M Townsend
Journal:  Adv Cancer Res       Date:  2021-04-28       Impact factor: 6.242

10.  Cisplatin Nephrotoxicity and Longitudinal Growth in Children With Solid Tumors: A Retrospective Cohort Study.

Authors:  Clímaco Andres Jiménez-Triana; Osvaldo D Castelán-Martínez; Rodolfo Rivas-Ruiz; Ricardo Jiménez-Méndez; Aurora Medina; Patricia Clark; Rod Rassekh; Gilberto Castañeda-Hernández; Bruce Carleton; Mara Medeiros
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.